Interbody fusion in degenerative lumbar spinal stenosis with additional posterolateral fusion using Escherichia coli-derived bone morphogenetic protein-2: A Pilot study

This case series investigated the efficacy and optimal dose of Escherichia coli-derived bone morphogenetic protein-2 (E.BMP-2) as a bone graft substitute for additional posterolateral spinal fusion, accompanying interbody fusion procedures, for treating lumbar degenerative spinal stenosis. This stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Sung Hoon, Koo, Ja Wook, Choe, DaeHyun, Hur, Jeong Min, Kim, Dong-Hong, Kang, Chang-Nam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
7100
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7302626/
https://www.ncbi.nlm.nih.gov/pubmed/32541470
http://dx.doi.org/10.1097/MD.0000000000020477

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7302626/
https://www.ncbi.nlm.nih.gov/pubmed/32541470
http://dx.doi.org/10.1097/MD.0000000000020477

Ejemplares similares